SCHEMBL718479

SCHEMBL718479

CC(=O)Oc1cc(C=Cc2ccccc2)cc(OC(C)=O)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.77
MAPT P10636 4/20 0.77
MEN1 O00255 3/20 0.77
KDM4E B2RXH2 2/20 0.77
TP53 P04637 2/20 0.77
CYP3A4 P08684 2/20 0.77
SMN1; SMN2 Q16637 2/20 0.77
LMNA P02545 1/20 0.77
TTR P02766 1/20 0.77
CYP19A1 P11511 1/20 0.71
ALDH1A1 P00352 2/20 0.53
USP2 O75604 1/20 0.53
HPGD P15428 1/20 0.53
TRPV1 Q8NER1 1/20 0.53
HSD17B10 Q99714 1/20 0.53
TUBB4A P04350 3/20 0.53
TUBB P07437 3/20 0.53
TUBA3C P0DPH7 3/20 0.53
TUBA1B P68363 3/20 0.53
TUBA4A P68366 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL718478 1.00 KMT2A (0.77) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL715253 0.89 LMNA (0.81) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL715254 0.89 LMNA (0.81) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL716895 0.88 KMT2A (0.60) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL716894 0.88 KMT2A (0.60) KMT2AMAPTMEN1KDM4ETP53
Triacetylresveratrol SCHEMBL717980 0.87 TTR (1.00) KMT2AMAPTMEN1KDM4ETP53
Triacetylresveratrol SCHEMBL717979 0.87 TTR (1.00) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL8927318 0.86 MAPT (0.58) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL716755 0.85 KMT2A (0.71) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL716756 0.85 KMT2A (0.71) KMT2AMAPTMEN1KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200188878-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2020-06-18 US disclosed
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2016-10-06 US disclosed
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 KMT2A 964/4885MAPT 3368/4885MEN1 698/4885
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 KMT2A 964/4885MAPT 3368/4885MEN1 698/4885
US-20200188878-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 KMT2A 964/4885MAPT 3368/4885MEN1 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.